Position in INCY
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$648,957
+$247,951 QoQ
Shares Held
6,895
+69.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Stratos Wealth Partners, LTD. holds $11,734,127 across 20 Biotechnology names. INCY ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZVRA |
Zevra Therapeutics, Inc.
|
408,000 | $3,802,560 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,299 | $1,473,135 | |
| 3 | PHAT |
Phathom Pharmaceuticals, Inc.
|
100,000 | $1,111,000 | |
| 4 | PLX |
Protalix BioTherapeutics, Inc.
|
500,000 | $1,085,000 | |
| 5 | INCY |
Incyte Corp
This page
|
6,895 | $648,957 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,715 | $579,319 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
6,640 | $493,086 | |
| 8 | EXEL |
Exelixis, Inc.
|
9,093 | $389,998 |
All Filings in INCY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $648,957 | 6,895 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $401,006 | 4,060 | Shares | Sole | 2026-01-20 | |
| No filing history on record for this holder in this stock. | ||||||